GSK1940029

topical inhibitor of stearoyl-coenzyme A desaturase 1

Also Known As:

1-(3,4-dichlorobenzyl)-N-(4-(hydroxymethyl)phenyl)-5-methyl-1H-1,2,3-triazole-4-carboxamide; 1H-1,2,3-triazole-4-carboxamide, 1-((3,4-dichlorophenyl)methyl)-N-(4-(hydroxymethyl)phenyl)-5-methyl-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Triazoles: 1533
      - GSK1940029: 1

Experts

1.	Brigandi, Richard A: 1 article (01/2019)
2.	Murnane, Amy A: 1 article (01/2019)
3.	Reedy, Beth Ann: 1 article (01/2019)
4.	Shakib, Sepehr: 1 article (01/2019)
5.	Zhu, John: 1 article (01/2019)

Related Diseases

1.	Acne Vulgaris 01/01/2019 - "GSK1940029 gel, a novel SCD-1 inhibitor, is being developed as a potential treatment for acne. "